M-ESLON CAPSULE (EXTENDED RELEASE)

国: カナダ

言語: 英語

ソース: Health Canada

即購入

製品の特徴 製品の特徴 (SPC)
11-06-2019

有効成分:

MORPHINE SULFATE

から入手可能:

ETHYPHARM INC

ATCコード:

N02AA01

INN(国際名):

MORPHINE

投薬量:

60MG

医薬品形態:

CAPSULE (EXTENDED RELEASE)

構図:

MORPHINE SULFATE 60MG

投与経路:

ORAL

パッケージ内のユニット:

20/50

処方タイプ:

Narcotic (CDSA I)

治療領域:

OPIATE AGONISTS

製品概要:

Active ingredient group (AIG) number: 0104545010; AHFS:

認証ステータス:

APPROVED

承認日:

2006-04-07

製品の特徴

                                _N_
_M-ESLON_
_® _
_(morphine sulfate) Product Monograph _
PRODUCT MONOGRAPH
N
M-ESLON
®
(Morphine Sulfate)
10 mg, 15 mg, 30 mg, 60 mg, 100 mg, 200 mg
Extended Release Capsules
Narcotic Analgesic
Ethypharm Inc.
1000 de la Gauchetière Ouest, Suite 2400
Date of Revision: June 11, 2019
Montréal, Québec, H3B 4W5
Submission Control No. 226278
_ _
_N_
_M-ESLON_
_® _
_(morphine sulfate) Product Monograph _
_Page 2 of 38 _
ACTIONS
Morphine is a narcotic analgesic which exerts an agonist effect at
specific, saturable opioid
receptors in the CNS and other tissues. In man, morphine produces a
variety of effects including
analgesia, constipation from decreased gastrointestinal motility,
suppression of the cough reflex,
respiratory depression from reduced responsiveness of the respiratory
centre to CO
2
, nausea and
vomiting via stimulation of the CTZ, changes in mood including
euphoria and dysphoria,
sedation, mental clouding, and alterations of the endocrine and
autonomic nervous systems.
The psychological effects are of longer duration than that of
analgesia. Morphine-induced
analgesia is relatively selective in that other sensory modalities
(touch, vision, hearing) are not
affected. Moderate doses of morphine are effective in relieving
clinical (pathological) pain and
increasing pain threshold to tolerate pain. The capacity to perceive
the sensation of pain may be
relatively unaltered. The analgesic effects of morphine are due to its
CNS action, i.e., limbic
system, hypothalamus, and centrally induced endocrinological effect.
At present, the exact
mechanism by which the opiates exert their effects remains unknown.
Morphine is readily absorbed from the gastrointestinal tract and after
s.c. or i.m. injection. Due to
first-pass metabolism in the liver, the effect of an oral dose is less
than after parenteral
administration. With repeated regular dosing, orally administered
morphine is about one-third as
potent as when given by i.m. injection. Morphine is primarily excreted
in the urine as morphine-
3- glucuronide. Abou
                                
                                完全なドキュメントを読む
                                
                            

他の言語のドキュメント

製品の特徴 製品の特徴 フランス語 11-06-2019

この製品に関連するアラートを検索

ドキュメントの履歴を表示する